Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group.
Narayan V, Harrison M, Cheng H, Kenfield S, Aggarwal R, Kwon D, McKay R, Hauger R, Hart N, Conzen S, Borno H, Jim H, Dicker A, Dorff T, Moslehi J, Mucci L, Parsons JK, Saad F, Soule H, Morgans A, Ryan CJ. Narayan V, et al. Among authors: mckay r. Urol Oncol. 2020 Mar;38(3):83-93. doi: 10.1016/j.urolonc.2019.10.006. Epub 2019 Nov 14. Urol Oncol. 2020. PMID: 31734020 Review.
Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease.
Sarkar RR, Patel SH, Parsons JK, Deka R, Kumar A, Einck JP, Mundt AJ, Kader AK, Kane CJ, Riviere P, McKay R, Murphy JD, Rose BS. Sarkar RR, et al. Among authors: mckay r. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):689-695. doi: 10.1038/s41391-020-0241-3. Epub 2020 Jun 8. Prostate Cancer Prostatic Dis. 2020. PMID: 32513967 Free PMC article.
Analysis of CDK12 alterations in a pan-cancer database.
Pan E, Cabal A, Javier-DesLoges J, Patel D, Panian J, Lee S, Shaya J, Nonato T, Xu X, Stewart T, Rose B, Shabaik A, Cohen E, Kurzrock R, Tamayo P, McKay RR. Pan E, et al. Among authors: mckay rr. Cancer Med. 2022 Feb;11(3):753-763. doi: 10.1002/cam4.4483. Epub 2021 Dec 12. Cancer Med. 2022. PMID: 34898046 Free PMC article.
Germline alterations among Hispanic men with prostate cancer.
Pan E, Shaya J, Madlensky L, Randall JM, Javier-Desloges J, Millard FE, Rose B, Parsons JK, Nielsen SM, Hatchell KE, Esplin ED, Nussbaum RL, Weise N, Murphy J, Martinez ME, McKay RR. Pan E, et al. Among authors: mckay rr. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):561-567. doi: 10.1038/s41391-022-00517-6. Epub 2022 Feb 28. Prostate Cancer Prostatic Dis. 2022. PMID: 35228665
Correction: Germline alterations among Hispanic men with prostate cancer.
Pan E, Shaya J, Madlensky L, Randall JM, Javier-Desloges J, Millard FE, Rose B, Parsons JK, Nielsen SM, Hatchell KE, Esplin ED, Nussbaum RL, Weise N, Murphy J, Martinez ME, McKay RR. Pan E, et al. Among authors: mckay rr. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):599. doi: 10.1038/s41391-022-00539-0. Prostate Cancer Prostatic Dis. 2022. PMID: 35488122 No abstract available.
Systemic Treatment of Bone Disease in Metastatic Urinary Malignancies.
Patel SH, Panian J, Bree K, Derweesh I, Millard F, Randall J, Mckay R. Patel SH, et al. Among authors: mckay r. Eur Urol Focus. 2020 Jan 15;6(1):17-25. doi: 10.1016/j.euf.2019.06.007. Epub 2019 Jun 27. Eur Urol Focus. 2020. PMID: 31255618 Review.
1,485 results